Details for Patent: 7,064,148
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 7,064,148 protect, and when does it expire?
Patent 7,064,148 protects AMITIZA and is included in one NDA.
This patent has fourteen patent family members in ten countries.
Summary for Patent: 7,064,148
Title: | Chloride channel opener |
Abstract: | Disclosed is a novel use of a prostaglandin compound as a chloride channel opener. According to the instant invention, chloride channels in a mammalian subject can be opened by a prostaglandin compound to facilitate chloride ion transportation. |
Inventor(s): | Ueno; Ryuji (Montgomery, MD), Cuppoletti; John (Cincinnati, OH) |
Assignee: | Sucampo AG (Zug, CH) |
Application Number: | 10/231,341 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,064,148 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,064,148
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-002 | Apr 29, 2008 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY OPENING CHLORIDE CHANNELS (CIC) | See Plans and Pricing | |||
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-002 | Apr 29, 2008 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMMALIAN SUBJECT | See Plans and Pricing | |||
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | METHOD FOR TREATING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED CONSTIPATION BY OPENING CIC CHANNELS | See Plans and Pricing | |||
Sucampo Pharma Llc | AMITIZA | lubiprostone | CAPSULE;ORAL | 021908-001 | Jan 31, 2006 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMMALIAN SUBJECT | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,064,148
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 036391 | See Plans and Pricing | |||
Argentina | 104392 | See Plans and Pricing | |||
Australia | 2002330747 | See Plans and Pricing | |||
Brazil | 0212233 | See Plans and Pricing | |||
Canada | 2458471 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |